Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q4 2025 Earnings

4NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.95

-0.68

-0.4

-0.13

Details

Expected EPS

-0.66236068962

Actual EPS

-0.130599

Surprise EPS

0.53

Surprise Percent

+80.28%

Description

Spyre Therapeutics (3920.F) has reported earnings of -0.130599 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.